These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 25457763)

  • 1. Early Reperfusion Can Reduce Infarction Size but not Salvaged Myocardial Size in Acute Myocardial Infarction Rats.
    Xia R; Lu X; Zhang B; Wang Y; Liao J; Zheng J; Gao F
    JACC Cardiovasc Imaging; 2015 May; 8(5):616-617. PubMed ID: 25457763
    [No Abstract]   [Full Text] [Related]  

  • 2. Lethal reperfusion injury in acute myocardial infarction: facts and unresolved issues.
    Garcia-Dorado D; Ruiz-Meana M; Piper HM
    Cardiovasc Res; 2009 Jul; 83(2):165-8. PubMed ID: 19502282
    [No Abstract]   [Full Text] [Related]  

  • 3. Critical Issues for the Translation of Cardioprotection.
    Heusch G
    Circ Res; 2017 Apr; 120(9):1477-1486. PubMed ID: 28450365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B-type natriuretic peptide at early reperfusion limits infarct size in the rat isolated heart.
    Burley DS; Baxter GF
    Basic Res Cardiol; 2007 Nov; 102(6):529-41. PubMed ID: 17896117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of acidic reperfusion on prolongation of intracellular acidosis and myocardial salvage.
    Inserte J; Barba I; Hernando V; Abellán A; Ruiz-Meana M; Rodríguez-Sinovas A; Garcia-Dorado D
    Cardiovasc Res; 2008 Mar; 77(4):782-90. PubMed ID: 18056767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infarct size reduction in acute myocardial infarction.
    McAlindon E; Bucciarelli-Ducci C; Suleiman MS; Baumbach A
    Heart; 2015 Jan; 101(2):155-60. PubMed ID: 24829367
    [No Abstract]   [Full Text] [Related]  

  • 7. Benefits of reperfusion beyond infarct size limitation.
    Takemura G; Nakagawa M; Kanamori H; Minatoguchi S; Fujiwara H
    Cardiovasc Res; 2009 Jul; 83(2):269-76. PubMed ID: 19176600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular basis of cardioprotection: signal transduction in ischemic pre-, post-, and remote conditioning.
    Heusch G
    Circ Res; 2015 Feb; 116(4):674-99. PubMed ID: 25677517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Durable Benefits of Cellular Postconditioning: Long-Term Effects of Allogeneic Cardiosphere-Derived Cells Infused After Reperfusion in Pigs with Acute Myocardial Infarction.
    Kanazawa H; Tseliou E; Dawkins JF; De Couto G; Gallet R; Malliaras K; Yee K; Kreke M; Valle I; Smith RR; Middleton RC; Ho CS; Dharmakumar R; Li D; Makkar RR; Fukuda K; Marbán L; Marbán E
    J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26857066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed postconditioning in the mouse heart in vivo.
    Roubille F; Franck-Miclo A; Covinhes A; Lafont C; Cransac F; Combes S; Vincent A; Fontanaud P; Sportouch-Dukhan C; Redt-Clouet C; Nargeot J; Piot C; Barrère-Lemaire S
    Circulation; 2011 Sep; 124(12):1330-6. PubMed ID: 21875909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined remote perconditioning and postconditioning failed to attenuate infarct size and contractile dysfunction in a rat model of coronary artery occlusion.
    Sachdeva J; Dai W; Gerczuk PZ; Kloner RA
    J Cardiovasc Pharmacol Ther; 2014 Nov; 19(6):567-73. PubMed ID: 24607766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reperfusion injury: doublethink or misnomer.
    Sobel BE; Zaman AK
    Coron Artery Dis; 2011 Nov; 22(7):515-7. PubMed ID: 21849893
    [No Abstract]   [Full Text] [Related]  

  • 13. Modifying the first minute of reperfusion: potential for myocardial salvage.
    Diaz RJ; Wilson GJ
    Cardiovasc Res; 2004 Apr; 62(1):4-6. PubMed ID: 15023547
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term inhibition of myocardial infarction by postconditioning during reperfusion.
    Mykytenko J; Kerendi F; Reeves JG; Kin H; Zatta AJ; Jiang R; Guyton RA; Vinten-Johansen J; Zhao ZQ
    Basic Res Cardiol; 2007 Jan; 102(1):90-100. PubMed ID: 17003965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure of erythropoietin to render jeopardized ischemic myocardium amenable to incremental salvage by early reperfusion.
    French CJ; Zaman AK; Sobel BE
    Coron Artery Dis; 2009 Jun; 20(4):295-9. PubMed ID: 19440068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracoronary delivery of DNAzymes targeting human EGR-1 reduces infarct size following myocardial ischaemia reperfusion.
    Bhindi R; Fahmy RG; McMahon AC; Khachigian LM; Lowe HC
    J Pathol; 2012 Jun; 227(2):157-64. PubMed ID: 22344601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Future of Remote Ischemic Conditioning.
    Przyklenk K; Whittaker P
    J Cardiovasc Pharmacol Ther; 2017 Jul; 22(4):295-296. PubMed ID: 28513214
    [No Abstract]   [Full Text] [Related]  

  • 18. [Endogenous cardioprotective mechanisms - what is it about and how does it work?].
    Beręsewicz A
    Kardiol Pol; 2011; 69 Suppl 3():59-66. PubMed ID: 22125205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Reperfusion and postconditioning in acute ST segment elevation myocardial infarction. A new paradigm for the treatment of acute myocardial infarction. From bench to bedside?].
    Lupi Herrera E; Gaspar J; González Pacheco H; Martínez Sánchez C; Pastelín Hernández G; Luna Ortiz P; Chávez Cosio E
    Arch Cardiol Mex; 2006; 76 Suppl 4():S76-101. PubMed ID: 17469337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nothing but natural: targeting natural IgM in ischaemia/reperfusion injury.
    Hofmann U; Bauersachs J; Frantz S
    Cardiovasc Res; 2010 Sep; 87(4):589-90. PubMed ID: 20573731
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.